{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:49:06Z","timestamp":1794512946133,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007703","name":"North Carolina State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008615","name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["63\/008,069"],"award-info":[{"award-number":["63\/008,069"]}],"id":[{"id":"10.13039\/100008615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["ECCS-1542015"],"award-info":[{"award-number":["ECCS-1542015"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R33-CA281875"],"award-info":[{"award-number":["R33-CA281875"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37-CA260223"],"award-info":[{"award-number":["R37-CA260223"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21-CA287221"],"award-info":[{"award-number":["R21-CA287221"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biomaterials.2024.122580","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T11:35:53Z","timestamp":1713180953000},"page":"122580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Implantable CAR T cell factories enhance solid tumor treatment"],"prefix":"10.1016","volume":"308","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1392-9148","authenticated-orcid":false,"given":"Sharda","family":"Pandit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3425-6456","authenticated-orcid":false,"given":"Pritha","family":"Agarwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8866-1270","authenticated-orcid":false,"given":"Feifei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9362-8328","authenticated-orcid":false,"given":"Anton","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Dotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2963-3293","authenticated-orcid":false,"given":"Yevgeny","family":"Brudno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2024.122580_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201700095","article-title":"Bioengineering solutions for manufacturing challenges in CAR T cells","volume":"13","author":"Piscopo","year":"2018","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.biomaterials.2024.122580_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/cancers11020191","article-title":"Chimeric antigen receptor T cell therapy for solid tumors: current status, obstacles and future strategies","volume":"11","author":"Heyman","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2024.122580_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fimmu.2019.00128","article-title":"CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment","volume":"10","author":"Martinez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.biomaterials.2024.122580_bib6","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41409-020-0956-8","article-title":"Value and affordability of CAR T-cell therapy in the United States","volume":"55","author":"Fiorenza","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.biomaterials.2024.122580_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/2643-3230.BCD-21-0084","article-title":"Scalable manufacturing of CAR T cells for cancer immunotherapy","volume":"2","author":"Abou-El-Enein","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.biomaterials.2024.122580_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41551-021-00842-6","article-title":"Rapid manufacturing of non-activated potent CAR T cells","volume":"6","author":"Ghassemi","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2024.122580_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.809754","article-title":"In-vivo induced CAR-T cell for the potential breakthrough to overcome the barriers of current CAR-T cell therapy","volume":"12","author":"Xin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-bioeng-070620-033348","article-title":"In situ programming of CAR T cells","volume":"23","author":"Parayath","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2024.122580_bib11","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.3389\/fimmu.2018.02593","article-title":"Making CAR T cells a solid option for solid tumors","volume":"9","author":"Schmidts","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/OTT.S190336","article-title":"Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors","volume":"12","author":"Yan","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.biomaterials.2024.122580_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ccell.2019.01.002","article-title":"Antitumor responses in the absence of toxicity in solid tumors by targeting B7-H3 via chimeric antigen receptor T cells","volume":"35","author":"Du","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2024.122580_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.omto.2020.03.019","article-title":"B7-H3-Targeted CAR-T cells exhibit potent antitumor effects on hematologic and solid tumors","volume":"17","author":"Zhang","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.biomaterials.2024.122580_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150807","article-title":"CAR T cell manufacturing from naive\/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome","volume":"132","author":"Arcangeli","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biomaterials.2024.122580_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106036","article-title":"Improving the ability of CAR-T cells to hit solid tumors: challenges and strategies","volume":"175","author":"Zhang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biomaterials.2024.122580_bib17","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.annonc.2021.07.018","article-title":"Early-phenotype CAR-T cells for the treatment of pediatric cancers","volume":"32","author":"Meyran","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI85631","article-title":"Selection bias: maintaining less-differentiated T cells for adoptive immunotherapy","volume":"126","author":"Xu","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biomaterials.2024.122580_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745109","article-title":"A correlation between differentiation phenotypes of infused T cells and anti-cancer immunotherapy","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3322","article-title":"Paths to stemness: building the ultimate antitumour T cell","volume":"12","author":"Gattinoni","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2024.122580_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910828","article-title":"Improving CAR T-cell persistence","volume":"22","author":"Pietrobon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2024.122580_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1671761","article-title":"In vivo generated human CAR T cells eradicate tumor cells","volume":"8","author":"Agarwal","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.biomaterials.2024.122580_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878209","article-title":"CAR-T cell performance: how to improve their persistence?","volume":"13","author":"L\u00f3pez-Cantillo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-022-01245-x","article-title":"Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells","author":"Agarwalla","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib25","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41551-021-00712-1","article-title":"Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets","volume":"5","author":"Hu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2024.122580_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn8264","article-title":"Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors","volume":"8","author":"Grosskopf","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2024.122580_bib27","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1021\/acs.accounts.0c00335","article-title":"Biomaterials in chimeric antigen receptor T-cell process development","volume":"53","author":"Cardle","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biomaterials.2024.122580_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jbm.a.31562","article-title":"T cell subset distributions following primary and secondary implantation at subcutaneous biomaterial implant sites","volume":"85","author":"Rodriguez","year":"2008","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.biomaterials.2024.122580_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100157","article-title":"Interfacing biomaterials with synthetic T cell immunity","volume":"10","author":"Su","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2024.122580_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000275","article-title":"Scaffold-mediated static transduction of T cells for CAR-T cell therapy","volume":"9","author":"Agarwalla","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2024.122580_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nbt.4047","article-title":"Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells","volume":"36","author":"Cheung","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120584","article-title":"Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy","volume":"268","author":"Isser","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2024.122580_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg5841","article-title":"Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma","volume":"7","author":"Ogunnaike","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2024.122580_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nbt.3104","article-title":"Biopolymer implants enhance the efficacy of adoptive T-cell therapy","volume":"33","author":"Stephan","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib35","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fimmu.2019.00931","article-title":"Biomaterial-based activation and expansion of tumor-specific T cells","volume":"10","author":"Schluck","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41578-019-0106-3","article-title":"Macroscale biomaterials strategies for local immunomodulation","volume":"4","author":"Dellacherie","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biomaterials.2024.122580_bib37","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/leu.2017.145","article-title":"High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients","volume":"31","author":"Pan","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.biomaterials.2024.122580_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202009489","article-title":"Delivery techniques for enhancing CAR T cell therapy against solid tumors","author":"Fu","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2024.122580_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.progpolymsci.2011.06.003","article-title":"Alginate: properties and biomedical applications","volume":"37","author":"Lee","year":"2012","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.biomaterials.2024.122580_bib40","doi-asserted-by":"crossref","DOI":"10.1039\/D2BM01753A","article-title":"Absorption rate governs cell transduction in dry macroporous scaffolds","author":"VanBlunk","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biomaterials.2024.122580_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.biomaterials.2024.122580_bib42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.msec.2014.06.002","article-title":"Current treatment options and drug delivery systems as potential therapeutic agents for ovarian cancer: a review","volume":"45","author":"Ye","year":"2014","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.biomaterials.2024.122580_bib43","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2024.122580_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110276","article-title":"Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy","volume":"128","author":"Gouvarchin Ghaleh","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2024.122580_bib45","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12033-012-9528-5","article-title":"Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations","volume":"53","author":"Denning","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12860-021-00397-z","article-title":"Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells","volume":"22","author":"Rajabzadeh","year":"2021","journal-title":"BMC Mol Cell Biol"},{"key":"10.1016\/j.biomaterials.2024.122580_bib47","unstructured":"RetroNectin reagent\u2014FAQs,.(n.d.). https:\/\/www.takarabio.com\/learning-centers\/gene-function\/t-cell-transduction-and-culture\/retronectin-faqs (accessed November 18, 2022).."},{"key":"10.1016\/j.biomaterials.2024.122580_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2024.02.013","article-title":"A biomaterial platform for T cell-specific gene delivery","author":"Pandit","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2024.122580_bib49","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2326-6066.CIR-17-0405","article-title":"Reducing ex vivo culture improves the antileukemic activity of chimeric antigen receptor (CAR) T cells","volume":"6","author":"Ghassemi","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biomaterials.2024.122580_bib50","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1039\/C6TB01713D","article-title":"3D porous chitosan\u2013alginate scaffolds promote proliferation and enrichment of cancer stem-like cells","volume":"4","author":"Florczyk","year":"2016","journal-title":"J. Mater. Chem. B Mater. Biol. Med."},{"key":"10.1016\/j.biomaterials.2024.122580_bib51","article-title":"3D printing scaffold vaccine for antitumor immunity","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2024.122580_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002737","article-title":"Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells","volume":"9","author":"Huckaby","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2024.122580_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41408-021-00508-1","article-title":"AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia","volume":"11","author":"Nawaz","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.biomaterials.2024.122580_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006292","article-title":"Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering","volume":"11","author":"Michels","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2024.122580_bib56","doi-asserted-by":"crossref","DOI":"10.3791\/64036","article-title":"Fabrication and use of dry macroporous alginate scaffolds for viral transduction of T cells","author":"VanBlunk","year":"2022","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biomaterials.2024.122580_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1109\/MCSE.2016.49","article-title":"OpenPNM: a pore Network modeling package","volume":"18","author":"Gostick","year":"2016","journal-title":"Comput. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2024.122580_bib58","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1200\/JCO.20.01342","article-title":"Anti-CD30 CAR-T cell therapy in relapsed and refractory hodgkin lymphoma","volume":"38","author":"Ramos","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122580_bib59","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41467-022-29647-0","article-title":"Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:05:40Z","timestamp":1777485940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":59,"alternative-id":["S0142961224001145"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122580","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implantable CAR T cell factories enhance solid tumor treatment","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122580"}}